239440-20-1
239440-20-1 性质
密度 | 1.48±0.1 g/cm3(Predicted) |
---|---|
储存条件 | Store at -20°C |
溶解度 | 溶于二甲基亚砜 |
形态 | 固体 |
酸度系数(pKa) | 11.35±0.46(Predicted) |
颜色 | 白色至米白色 |
239440-20-1 用途与合成方法
IC50: 0.3 nM (Na + /H + -exchange, Rat lymphocytes), 3.1 nM (Na + /H + -exchange, Human platelet), 6.5 nM (Na + /H + -exchange, Rat platelet)
FR183998 free base is a Na + /H + -exchange inhibitor, with IC 50 s of 0.3 nM, 6.5 nM and 3.1 nM by measurement of pH i change in rat lymphocytes, rat and human platelets, respectively.
FR183998 (0.1 and 1.0 mg/kg, i.v.) shows no effect hemodynamic parameters, and does not affect mean blood pressure and heart rate in conscious rats. Pretreatment of 0.01, 0.032, 0.10 mg/kg FR183998 or posttreament of 0.032 and 0.10 mg/kg FR183998 via intravenous administration, dose-dependently reuces reperfusion-induced ventricular fibrillation (VF) and mortality in reperfusion-induced arrhythmias in anesthetized rats, with ED 50 s against VF of 0.015 mg/kg and 0.070 mg/kg, respectively. FR183998 also reduces myocardial infarct sizes, and suppresses the arrhythmias in anesthetized rats. FR183998 (1 mg/kg, i.v.) reduces the increase in serum levels of alanine transaminase, aspartate transaminase, and lactate dehydrogenase induced by hepatic I/R, and prevents the incidences of hepatic necrosis, apoptosis, and neutrophil infiltration. FR183998 blocks the I/R-induced activation of the NF-κB, reduces induction of iNOS and inhibits the production of nitric oxide. FR183998 also decreases the expression of the iNOS gene antisense transcript in the liver of hepatic I/R rats.
239440-20-1 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-08-19 | HY-100302 | 239440-20-1 | 239440-20-1 | 1 mg | 1500 |
2024-08-19 | HY-100302 | 239440-20-1 | 239440-20-1 | 5 mg | 3800 |